When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNPX - Genprex rockets 308% on accelerated review status for Oncoprex in lung cancer
Genprex Inc.
Nano cap Genprex (GNPX+308.3%) rallies on a healthy 45x surge in volume in reaction to Fast Track status in the U.S. for immunogene therapy Oncoprex, combined with AstraZeneca's Tagrisso (osimertinib), for the treatment of patients with EGFR mutation-positive non-small cell lung cancer (NSCLC) who have progressed on osimertinib alone.
More news on: Genprex, Inc., Healthcare stocks news, Stocks on the move,